513 related articles for article (PubMed ID: 12412775)
1. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
2. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
Arnold A
Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
[TBL] [Abstract][Full Text] [Related]
3. Putative parathyroid tumor suppressor on 1p: independent molecular mechanisms of tumorigenesis from 11q allelic loss.
Imanishi Y; Tahara H
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S165-7. PubMed ID: 11576946
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of parathyroid tumors.
Carling T
Trends Endocrinol Metab; 2001 Mar; 12(2):53-8. PubMed ID: 11167122
[TBL] [Abstract][Full Text] [Related]
6. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors.
Hosokawa Y; Pollak MR; Brown EM; Arnold A
J Clin Endocrinol Metab; 1995 Nov; 80(11):3107-10. PubMed ID: 7593409
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 in parathyroid disease.
Mallya SM; Arnold A
Front Biosci; 2000 Mar; 5():D367-71. PubMed ID: 10704427
[TBL] [Abstract][Full Text] [Related]
9. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
10. CDK4/6 Dependence of Cyclin D1-Driven Parathyroid Neoplasia in Transgenic Mice.
Costa-Guda J; Corrado K; Bellizzi J; Romano R; Saria E; Saucier K; Rose M; Shah S; Alander C; Mallya S; Arnold A
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32877917
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of hyperparathyroidism and potential targets for drug development.
Krebs LJ; Arnold A
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):167-79. PubMed ID: 12476790
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.
Imanishi Y; Hosokawa Y; Yoshimoto K; Schipani E; Mallya S; Papanikolaou A; Kifor O; Tokura T; Sablosky M; Ledgard F; Gronowicz G; Wang TC; Schmidt EV; Hall C; Brown EM; Bronson R; Arnold A
J Clin Invest; 2001 May; 107(9):1093-102. PubMed ID: 11342573
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of primary hyperparathyroidism.
Hendy GN
Rev Endocr Metab Disord; 2000 Nov; 1(4):297-305. PubMed ID: 11706744
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in primary and secondary hyperparathyroidism.
Shan L; Nakamura Y; Nakamura M; Yokoi T; Kakudo K
Pathol Int; 1998 Aug; 48(8):569-74. PubMed ID: 9736402
[TBL] [Abstract][Full Text] [Related]
15. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
Marx SJ; Simonds WF; Agarwal SK; Burns AL; Weinstein LS; Cochran C; Skarulis MC; Spiegel AM; Libutti SK; Alexander HR; Chen CC; Chang R; Chandrasekharappa SC; Collins FS
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
[TBL] [Abstract][Full Text] [Related]
16. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
17. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
[TBL] [Abstract][Full Text] [Related]
18. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
19. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
[TBL] [Abstract][Full Text] [Related]
20. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
